VIR

Vir Biotechnology, Inc.

VIR · CIK 1706431 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$0.1B
20192025
Net Income−$0.4B
20192025
Operating CF−$0.4B
20192025
Free Cash Flow−$0.4B
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.1B$0.1B$0.1B$1.6B$1.1B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.1B$0.1B——
Gross Profit———————
R&D Expense$0.5B$0.5B$0.6B$0.5B$0.4B$0.3B$0.1B
SG&A Expense$0.1B$0.1B$0.2B$0.2B$0.2B——
Operating Income$-0.5B$-0.6B$-0.7B$0.8B$0.4B$-0.3B$-0.2B
Net Income$-0.4B$-0.5B$-0.6B$0.5B$0.5B$-0.1B$-0.1B
EPS (Basic)$-3.16$-3.83$-4.59$3.89$4.07$-0.83$-0.69
EPS (Diluted)$-3.16$-3.83$-4.59$3.83$3.96$-0.83$-0.71

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$1.0B$1.4B$1.9B$2.8B$2.0B$0.9B$0.5B
Current Assets$0.5B$1.0B$1.6B$2.5B$1.6B$0.8B$0.4B
Cash & Equivalents$0.2B$0.2B$0.2B$0.8B$0.3B$0.4B$0.1B
Total Liabilities$0.2B$0.2B$0.3B$0.7B$0.5B$0.2B$0.1B
Current Liabilities$0.1B$0.1B$0.2B$0.5B$0.3B$0.1B$0.1B
Stockholders' Equity———$2.1B$1.4B$0.7B$0.4B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.4B$-0.4B$-0.8B$1.7B$-0.0B$-0.2B$-0.1B
Investing Cash Flow$0.3B$0.5B$0.2B$-1.2B$-0.1B$-0.0B$-0.3B
Capital Expenditures$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.1B$0.5B$0.4B
← Companies